The stock price of Mylan is soaring, but the pharmaceutical company might not be out of the woods yet. After a summer of bad headlines, Congressional testimony, and agreements to pay back millions to the government, the Pentagon is looking at how much Mylan has been overcharging since 2008.
from Gizmodo http://ift.tt/2dTNSvf
No comments:
Post a Comment